Akut Astım Krizi

Satuk Buğra Han Bozatlı

doi:10.37609/akya.2615

Yazarlar

Satuk Buğra Han Bozatlı

DOI: https://doi.org/10.37609/akya.2615.c8625

Özet

Astım solunum yolunun ataklarla seyreden kronik hastalığıdır. Her yaştan insanı etkileyebilir. Etiyolojisinde genetik yapı ve çevresel faktörler etkilidir. Acil servise başvuru şekli genellikle nefes darlığı ve hışıltılı solunum ile karakterizedir. Çoğunluğu medikal tedavi ile hızla düzelir. Tedaviye yeterli cevap alınamayan bazı özel durumlarda yoğun bakım şartlarında tedavi edilmesi gerekir. Uzun dönem tedavisi ve rehabilitasyonunda medikal tedaviye ek olarak allerjen faktörlerden de uzak durulması, kişiye özel astım eylem planının düzenlenmesi önemlidir.

Referanslar

Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention（2022 update）［EB/OL］. ［2022-05-25］. https://ginasthma.org/wp-content/uploads/2022/05/GINA-MainReport-2022-FINAL-22-05-03-WMS.pdf.

Tarraf H, Aydin O, Mungan D, Albader M, Mahboub B, Doble A, et al. Prevalence of asthma among the adult general population of five Middle Eastern countries: results of the SNAPSHOT program. BMC Pulm Med. 2018;18:1-14.

To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC public health. 2012;12(1):1-8.

Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, et al. After asthma: redefining airways diseases. The Lancet. 2018;391(10118):350-400.

Güngör S. Astımda Erişkinde Atak Tedavisi. GÖĞÜS HASTALIKLARI.149.

Asher MI, García-Marcos L, Pearce NE, Strachan DP. Trends in worldwide asthma prevalence. Eur Respir J. 2020;56(6).

Beasley R, Crane J, Lai CK, Pearce N. Prevalence and etiology of asthma. J Allergy Clin Immunol. 2000;105(2):S466-S72.

Kurt E, Metintas S, Basyigit I, Bulut I, Coskun E, Dabak S, et al. PARFAIT. Study of Turkish Thoracic Society Asthma–Allergy Working Group, Prevalence and risk factors of allergies in Turkey: results of a multicentric cross-sectional study inchildren. Pediatr Allergy Immunol. 2007;18(7):566-74.

Pignataro F, Bonini M, Forgione A, Melandri S, Usmani O. Asthma and gender: the female lung.Pharmacol Res. 2017;119:384-90.

Beuther DA, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care Med. 2006;174(2):112-9.

Ober C, Yao TC. The genetics of asthma and allergic disease: a 21st century perspective.Immunol Rev. 2011;242(1):10-30.

Calderón MA, Linneberg A, Kleine-Tebbe J, De Blay F, de Rojas DHF, Virchow JC, et al. Respiratory allergy caused by house dust mites: what do we really know?J Allergy Clin Immunol. 2015;136(1):38-48.

Çımrın AH. Meslek astımı-Türkiye gerçeği. Toraks Dergisi. 2000;1:87-9.

Kynyk JA, Mastronarde JG, McCallister JW. Asthma, the sex difference. Curr Opin Pul Med. 2011;17(1):6-11.

Moorman JE, Zahran H, Truman BI, Molla MT, Control CfD, Prevention. Current asthma prevalence-United States, 2006-2008. MMWR Surveill Summ. 2011;60(Suppl):84-6.

Thomsen SF. Genetics of asthma: an introduction for the clinician. Eur Clin Respir J. 2015;2(1):24643.

Keskin O, Farzan N, Birben E, Akel H, Karaaslan C, Maitland‐van der Zee AH, et al. Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review. Clin Transl Allergy. 2019;9(1):2.

Keskin O, Uluca Ü, Birben E, Coşkun Y, Ozkars MY, Keskin M, et al. Genetic associations of the response to inhaled corticosteroids in children during an asthma exacerbation. Pediatr Allergy Immunol. 2016;27(5):507-13.

March ME, Sleiman PM, Hakonarson H. Genetic polymorphisms and associated susceptibility to asthma. In J Gen Med. 2013:253-65.

Ho S-M. Environmental epigenetics of asthma: an update. J Allergy Clin Immunal. 2010;126(3):453-65.

Busse PJ, Cohn RD, Salo PM, Zeldin DC. Characteristics of allergic sensitization among asthmatic adults older than 55 years: results from the National Health and Nutrition Examination Survey, 2005-2006. Ann Allergy Asthma Immunol. 2013;110(4):247-52.

Barnthouse M, Jones BL. The impact of environmental chronic and toxic stress on asthma. Clin Rev Allergy Immunol. 2019;57:427-38.

Flodin U, Ponsson P, Ziegler J, Axelson O. An epidemiologic study of bronchial asthma and smoking. Epidemiology. 1995;6(5):503-5.

Toren K, Hermansson B-A. Incidence rate of adult-onset asthma in relation to age, sex, atopy and smoking: a Swedish population-based study of 15813 adults. Int J Tuberc Dis. 1999;3(3):192-7.

Plaschke PP, Janson C, Norrman E, Bjornsson E, Ellbjar S, Jarvholm B. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Medi. 2000;162(3):920-4.

Chen Y, Dales R, Tang M, Krewski D. Sex-related interactive effect of smoking and household pets on asthma incidence. Eur Respir J. 2002;20(5):1162-6.

Piipari R, Jaakkola J, Jaakkola N, Jaakkola M. Smoking and asthma in adults. Eur Respir J. 2004;24(5):734-9.

Tommola M, Ilmarinen P, Tuomisto LE, Haanpää J, Kankaanranta T, Niemelä O, et al. The effect of smoking on lung function: a clinical study of adult-onset asthma. Eur Respir J. 2016;48(5):1298-306.

Skorge TD, Eagan TM, Eide GE, Gulsvik A, Bakke PS. The adult incidence of asthma and respiratory symptoms by passive smoking in utero or in childhood. Am J Respir Crit Care Med. 2005;172(1):61-6.

Spears M, Cameron E, Chaudhuri R, Thomson NC. Challenges of treating asthma in people who smoke. Expert Rev Clin Immunol. 2010;6(2):257-68.

Chalmers G, Macleod K, Little S, Thomson L, McSharry C, Thomson N. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 2002;57(3):226-30.

Lazarus SC, Chinchilli VM, Rollings NJ, Boushey HA, Cherniack R, Craig TJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med. 2007;175(8):783-90.

Burke H, Leonardi-Bee J, Hashim A, Pine-Abata H, Chen Y, Cook DG, et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics. 2012;129(4):735-44.

de Marco R, Locatelli F, Cerveri I, Bugiani M, Marinoni A, Giammanco G. Incidence and remission of asthma: A retrospective study on the natural history of asthma in Italy. J Allergy Clin Immunol. 2002;110(2):228-35.

Vozoris NT, Stanbrook MB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med. 2011;105(3):477-84.

Cerveri I, Cazzoletti L, Corsico AG, Marcon A, Niniano R, Grosso A, et al. The impact of cigarette smoking on asthma: a population-based international cohort study. Int Arch Allergy Immunol. 2012;158(2):175-83.

To T, Stanojevic S, Moores G, Gershon A, Bateman E, Cruz A, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey https://www. ncbi. nlm. nih. gov/pmc/articles. BMC Public Health PMC3353191. 2012.

Gaffin JM, Phipatanakul W. The role of indoor allergens in the development of asthma. Curr Opin Allergy Clin Immunol. 2009;9(2):128.

Lazic N, Roberts G, Custovic A, Belgrave D, Bishop C, Winn J, et al. Multiple atopy phenotypes and their associations with asthma: similar findings from two birth cohorts. Allergy. 2013;68(6):764-70.

Loo CKJ, Foty RG, Wheeler AJ, Miller JD, Evans G, Stieb DM, et al. Do Questions Reflecting Indoor Air Pollutant Exposure from a Questionnaire Predict Direct Measure of Exposure in Owner-Occupied Houses? Int J Environ Res Public Health. 2010;7(8):3270-97.

Sheehan WJ, Phipatanakul W. Indoor allergen exposure and asthma outcomes. Curr Opin Pediatr. 2016;28(6):772-7.

Phipatanakul W. Environmental factors and childhood asthma. Pediatr Ann. 2006;35(9):646-56.

Sharpe RA, Bearman N, Thornton CR, Husk K, Osborne NJ. Indoor fungal diversity and asthma: a meta-analysis and systematic review of risk factors. J Allergy Clin Immunol. 2015;135(1):110-22.

Baur X, Sigsgaard T, Aasen TB, Burge PS, Heederik D, Henneberger P, et al. Guidelines for the management of work-related asthma. Eur Respir J. 2012;39(3):529-45.

Akpinar-Elci M, Cimrin AH, Elci OC. Prevalence and risk factors of occupational asthma among hairdressers in Turkey. J Occup Environ Med. 2002;44(6):585-90.

Nicholson PJ, Cullinan P, Taylor AJ, Burge PS, Boyle C. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med. 2005;62(5):290-9.

Tarlo SM, Malo JL. An official ATS proceedings: asthma in the workplace: the Third Jack Pepys Workshop on Asthma in the Workplace: answered and unanswered questions. Proc Am Thorac Soc. 2009;6(4):339-49.

Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med. 2014;370(7):640-9.

Silverman RA, Ito K. Age-related association of fine particles and ozone with severe acute asthma in New York City. J Allergy Clin Immunol. 2010;125(2):367-73.e5.

Weiss ST. Obesity: insight into the origins of asthma. Nat Immunol. 2005;6(6):537-9.

Sutherland ER. Linking obesity and asthma.Ann N Y Acad Sci. 2014;1311(1):31-41.

Safiri S, Carson-Chahhoud K, Karamzad N, Sullman MJM, Nejadghaderi SA, Taghizadieh A, et al. Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019. Chest. 2022;161(2):318-29.

Cardet JC, Chang K-L, Rooks BJ, Carroll JK, Celedón JC, Coyne-Beasley T, et al. Socioeconomic status associates with worse asthma morbidity among Black and Latinx adults. J Allergy Clin Immunol. 2022;150(4):841-9.e4.

Grant T, Croce E, Matsui EC. Asthma and the social determinants of health. Ann Allergy Asthma Immunol. 2022;128(1):5-11.

Singh SK, Gupta J, Sharma H, Pedgaonkar SP, Gupta N. Socio-economic Correlates and Spatial Heterogeneity in the Prevalence of Asthma among Young Women in India. BMC Pulm Med. 2020;20(1):190.

Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, et al. Identification of asthma phenotypes using cluster analysis in the Severe Am J Respir Crit Care Med. 2010;181(4):315-23.

Covar RA, Spahn JD, Murphy JR, Szefler SJ. Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med. 2004;170(3):234-41.

Liu MC, Hubbard WC, Proud D, Stealey BA, Galli SJ, Kagey-Sobotka A, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis. 1991;144(1):51-8.

Riccio MM, Proud D. Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes. J Allergy Clin Immunol. 1996;97(6):1252-63.

Peebles RS, Jr., Permutt S, Togias A. Rapid reversibility of the allergen-induced pulmonary late-phase reaction by an intravenous beta2-agonist. J Appl Physiol (1985). 1998;84(5):1500-5.

Jahnsen FL, Moloney ED, Hogan T, Upham JW, Burke CM, Holt PG. Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax. 2001;56(11):823-6.

Bousquet J, Chanez P, Lacoste JY, Barnéon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323(15):1033-9.

Wong CK, Cheung PF, Ip WK, Lam CW. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol. 2007;37(1):85-96.

Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med. 2002;346(22):1699-705.

Karaca S, Civelek E, Karaca M, Sahiner UM, Ozgul RK, Kocabas CN, et al. Allergy-specific phenome-wide association study for immunogenes in Turkish children.Sci Rep. 2016;6(1):1-7.

Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999;160(3):1001-8.

Mitchell HW, Sparrow MP. Increased responsiveness to cholinergic stimulation of small compared to large diameter cartilaginous bronchi. Eur Respir J. 1994;7(2):298-305.

Adler A, Cowley EA, Bates JH, Eidelman DH. Airway-parenchymal interdependence after airway contraction in rat lung explants. J Appl Physiol (1985). 1998;85(1):231-7.

Wagner EM, Liu MC, Weinmann GG, Permutt S, Bleecker ER. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis. 1990;141(3):584-8.

Brown RH, Mitzner W. The myth of maximal airway responsiveness in vivo. J Appl Physiol (1985). 1998;85(6):2012-7.

King GG, Carroll JD, Müller NL, Whittall KP, Gao M, Nakano Y, et al. Heterogeneity of narrowing in normal and asthmatic airways measured by HRCT. Eur Respir J. 2004;24(2):211-8.

de Lange EE, Altes TA, Patrie JT, Gaare JD, Knake JJ, Mugler JP, 3rd, et al. Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry. Chest. 2006;130(4):1055-62.

Dunican EM, Watchorn DC, Fahy JV. Autopsy and Imaging Studies of Mucus in Asthma. Lessons Learned about Disease Mechanisms and the Role of Mucus in Airflow Obstruction. Ann Am Thorac Soc. 2018;15(Suppl 3):S184-s91.

Svenningsen S, Haider E, Boylan C, Mukherjee M, Eddy RL, Capaldi DPI, et al. CT and Functional MRI to Evaluate Airway Mucus in Severe Asthma. Chest. 2019;155(6):1178-89.

Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007;175(7):661-6.

Mebrahtu TF, Feltbower RG, Greenwood DC, Parslow RC. Childhood body mass index and wheezing disorders: a systematic review and meta‐analysis. Pediatr Allergy Immunol. 2015;26(1):62-72.

Rodríguez MA, Winkleby MA, Ahn D, Sundquist J, Kraemer HC. Identification of population subgroups of children and adolescents with high asthma prevalence: findings from the Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med. 2002;156(3):269-75.

Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemière C, et al. Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma. JAMA. 2017;317(3):269-79.

Özdilekcan, Ç. (2018). ERİŞKİNLERDE KRONİK ÖKSÜRÜK: ETYOLOJİK, TANISAL VE TEDAVİ İLE İLGİLİ YAKLAŞIMLAR. CBU-SBED, 5(2), 47-51.

Woodruff PG, Emond SD, Singh AK, Camargo CA, Jr. Sudden-onset severe acute asthma: clinical features and response to therapy. Acad Emerg Med. 1998;5(7):695-701.

Roe PF. SUDDEN DEATH IN ASTHMA. Br J Dis Chest. 1965;59:158-63.

Wasserfallen JB, Schaller MD, Feihl F, Perret CH. Sudden asphyxic asthma: a distinct entity? Am Rev Respir Dis. 1990;142(1):108-11.

Sur S, Crotty TB, Kephart GM, Hyma BA, Colby TV, Reed CE, et al. Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis. 1993;148(3):713-9.

Hederos C-A, Janson S, Andersson H, Hedlin G. Chest x-ray investigation in newly discovered asthma. Pediatr Allergy Immunol. 2004;15(2):163-5.

Tsai TW, Gallagher EJ, Lombardi G, Gennis P, Carter W. Guidelines for the selective ordering of admission chest radiography in adult obstructive airway disease. Ann Emerg Med. 1993;22(12):1854-8.

Findley LJ, Sahn SA. The value of chest roentgenograms in acute asthma in adults. Chest. 1981;80(5):535-6.

Zieverink SE, Harper AP, Holden RW, Klatte EC, Brittain H. Emergency room radiography of asthma: an efficacy study. Radiology. 1982;145(1):27-9.

Aronson S, Gennis P, Kelly D, Landis R, Gallagher J. The value of routine admission chest radiographs in adult asthmatics. Ann Emerg Med. 1989;18(11):1206-8.

Paganin F, Séneterre E, Chanez P, Daurés JP, Bruel JM, Michel FB, et al. Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med. 1996;153(1):110-4.

Mahdavi MMB, Arabfard M, Rafati M, Ghanei M. A Computer-based Analysis for Identification and Quantification of Small Airway Disease in Lung Computed Tomography Images: A Comprehensive Review for Radiologists. J Thorac Imaging. 2023;38(1):W1-W18.

Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70-e88.

Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60(1).

Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-68.

Coates AL, Wanger J, Cockcroft DW, Culver BH, Diamant Z, Gauvreau G, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017;49(5).

Park HW, Song WJ, Chang YS, Cho SH, Datta S, Weiss ST, et al. Bronchodilator response following methacholine-induced bronchoconstriction predicts acute asthma exacerbations. Eur Respir J. 2016;48(1):104-14.

Kirenga BJ, Schwartz JI, de Jong C, van der Molen T, Okot-Nwang M. Guidance on the diagnosis and management of asthma among adults in resource limited settings. Afr Health Sci. 2015;15(4):1189-99.

Papiris S, Kotanidou A, Malagari K, Roussos C. Clinical review: Severe asthma. Crit Care . 2001;6(1):30.

Brenner B, Corbridge T, Kazzi A. Intubation and mechanical ventilation of the asthmatic patient in respiratory failure. J Emerg Med. 2009;37(2 Suppl):S23-34.

National Asthma Education and Prevention Program: Expert panel report II: Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute (NIH publication no. 97-4051), Bethesda, MD 1997

McFadden ER, Jr., Lyons HA. Arterial-blood gas tension in asthma. N Engl J Med. 1968;278(19):1027-32.

Martin TG, Elenbaas RM, Pingleton SH. Use of peak expiratory flow rates to eliminate unnecessary arterial blood gases in acute asthma. Ann Emerg Med. 1982;11(2):70-3.

Nowak RM, Tomlanovich MC, Sarkar DD, Kvale PA, Anderson JA. Arterial blood gases and pulmonary function testing in acute bronchial asthma. Predicting patient outcomes. JAMA. 1983;249(15):2043-6.

Høst A, Andrae S, Charkin S, Diaz-Vázquez C, Dreborg S, Eigenmann PA, et al. Allergy testing in children: why, who, when and how? Allergy. 2003;58(7):559-69.

British guideline on the management of asthma. A national clinical guideline. September 2016; available from https://www.brit-thoracic. org.uk.

KÖSE UDSŞ. Astım Tedavisinde Uyumu Etkileyen Faktörler ve Çözüm Önerileri. Klinik Tıp Pediatri Dergisi.9(1):11-5.

OĞUZÜLGEN İ, Köktürk N, IŞIKDOĞAN T. Turkish validation study of Morisky 8 item medication adherence questionnaire MMAS 8 in patients with asthma and chronic obstructive pulmonary disease. TUBERKULOZ VE TORAK-TUBERK TORAKS. 2014;62(2).

AYDIN Ö, BAVBEK S, ÇELİK G, EDİGER D, ERDİNÇ M, GEMİCİOĞLU B, et al. Astım Tanı ve Tedavi Rehberi2020 Güncellemesi. 2020.

Brenner BE, Abraham E, Simon RR. Position and diaphoresis in acute asthma. Am J Med. 1983;74(6):1005-9.

Kelsen SG, Kelsen DP, Fleeger BF, Jones RC, Rodman T. Emergency room assessment and treatment of patients with acute asthma. Adequacy of the conventional approach. Am J Med. 1978;64(4):622-8.

British guideline on the management of asthma. Thorax. 2014;69 Suppl 1:1-192.

Perrin K, Wijesinghe M, Healy B, Wadsworth K, Bowditch R, Bibby S, et al. Randomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma. Thorax. 2011;66(11):937-41.

Cloutier MM, Baptist AP, Blake KV, Brooks EG, Bryant-Stephens T, DiMango E, et al. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol. 2020;146(6):1217-70.

Turner JR, Corkery KJ, Eckman D, Gelb AM, Lipavsky A, Sheppard D. Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction. Chest. 1988;93(3):476-81.

Idris AH, McDermott MF, Raucci JC, Morrabel A, McGorray S, Hendeles L. Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest. 1993;103(3):665-72.

Newman KB, Milne S, Hamilton C, Hall K. A comparison of albuterol administered by metered-dose inhaler and spacer with albuterol by nebulizer in adults presenting to an urban emergency department with acute asthma. Chest. 2002;121(4):1036-41.

Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. 2013;2013(9):Cd000052.

Dhuper S, Chandra A, Ahmed A, Bista S, Moghekar A, Verma R, et al. Efficacy and cost comparisons of bronchodilatator administration between metered dose inhalers with disposable spacers and nebulizers for acute asthma treatment. J Emerg Med. 2011;40(3):247-55.

Moriates C, Feldman L. Nebulized bronchodilators instead of metered-dose inhalers for obstructive pulmonary symptoms. J Hosp Med. 2015;10(10):691-3.

Shrestha M, Bidadi K, Gourlay S, Hayes J. Continuous vs intermittent albuterol, at high and low doses, in the treatment of severe acute asthma in adults. Chest. 1996;110(1):42-7.

Camargo CA, Jr., Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev. 2003;2003(4):Cd001115.

Travers A, Jones AP, Kelly K, Barker SJ, Camargo CA, Rowe BH. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev. 2001;2001(2):Cd002988.

Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 2001(1):Cd002178.

Menzies-Gow A, Busse WW, Castro M, Jackson DJ. Prevention and Treatment of Asthma Exacerbations in Adults. J Allergy Clin Immunol Pract. 2021;9(7):2578-86.

Fanta CH, Rossing TH, McFadden ER, Jr. Glucocorticoids in acute asthma. A critical controlled trial. Am J Med. 1983;74(5):845-51.

Martins DT, Carlos K, Carvalho LB, Prado LB, Fransolin C, Atallah AN, et al. A randomized clinical trial on inhaled ciclesonide for managing acute asthma in the emergency room. Sao Paulo Med J. 2022;140(3):430-8.

Edmonds ML, Camargo CA, Jr., Brenner BE, Rowe BH. Replacement of oral corticosteroids with inhaled corticosteroids in the treatment of acute asthma following emergency department discharge: a meta-analysis. Chest. 2002;121(6):1798-805.

FitzGerald JM, Shragge D, Haddon J, Jennings B, Lee J, Bai T, et al. A randomized, controlled trial of high dose, inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation. Can Respir J. 2000;7(1):61-7.

Rodrigo GJ. Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. Am J Respir Crit Care Med. 2005;171(11):1231-6.

Brenner BE, Chavda KK, Camargo CA, Jr. Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department. Ann Emerg Med. 2000;36(5):417-26.

Harrison TW, Oborne J, Newton S, Tattersfield AE. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet. 2004;363(9405):271-5.

Edmonds ML, Milan SJ, Camargo CA, Jr., Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev. 2012;12(12):Cd002308.

Marghli S, Bouhamed C, Sghaier A, Chebbi N, Dlala I, Bettout S, et al. Nebulized budesonide combined with systemic corticosteroid vs systemic corticosteroid alone in acute severe asthma managed in the emergency department: a randomized controlled trial. BMC Emerg Med. 2022;22(1):134.

McFadden ER, Jr. Inhaled glucocorticoids and acute asthma: therapeutic breakthrough or nonspecific effect? Am J Respir Crit Care Med. 1998;157(3 Pt 1):677-8.

Blais L, Ernst P, Boivin JF, Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med. 1998;158(1):126-32.

Sin DD, Tu JV. Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics. Eur Respir J. 2001;17(3):380-5.

Emerman CL, Cydulka RK. A randomized comparison of 100-mg vs 500-mg dose of methylprednisolone in the treatment of acute asthma. Chest. 1995;107(6):1559-63.

Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343(5):332-6.

Buhl R. Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma. Allergy. 2006;61(5):518-26.

Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med. 1999;159(9):941-55.

Barnes PJ. Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol. 1998;102(4 Pt 1):531-8.

Pauwels RA, Yernault JC, Demedts MG, Geusens P. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group. Am J Respir Crit Care Med. 1998;157(3 Pt 1):827-32.

Kim MH, Rhee CK, Shim JS, Park SY, Yoo KH, Kim BY, et al. Inhaled Corticosteroids in Asthma and the Risk of Pneumonia. Allergy Asthma Immunol Res. 2019;11(6):795-805.

Nair P, Milan SJ, Rowe BH. Addition of intravenous aminophylline to inhaled beta(2)-agonists in adults with acute asthma. Cochrane Database Syst Rev. 2012;12(12):Cd002742.

Green SM, Rothrock SG. Intravenous magnesium for acute asthma: failure to decrease emergency treatment duration or need for hospitalization. Ann Emerg Med. 1992;21(3):260-5.

Alter HJ, Koepsell TD, Hilty WM. Intravenous magnesium as an adjuvant in acute bronchospasm: a meta-analysis. Ann Emerg Med. 2000;36(3):191-7.

Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA, Jr. Intravenous magnesium sulfate treatment for acute asthma in the emergency department: a systematic review of the literature. Ann Emerg Med. 2000;36(3):181-90.

Kew KM, Kirtchuk L, Michell CI. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department. Cochrane Database Syst Rev. 2014(5):Cd010909.

Le Conte P, Terzi N, Mortamet G, Abroug F, Carteaux G, Charasse C, et al. Management of severe asthma exacerbation: guidelines from the Société Française de Médecine d'Urgence, the Société de Réanimation de Langue Française and the French Group for Pediatric Intensive Care and Emergencies. Ann Intensive Care. 2019;9(1):115.

de Freitas Dantas Gomes EL, Costa D, Germano SM, Borges PV, Sampaio LMM. Effects of CPAP on clinical variables and autonomic modulation in children during an asthma attack. Respir Physiol Neurobiol. 2013;188(1):66-70.

Shivaram U, Miro AM, Cash ME, Finch PJP, Heurich AE, Kamholz SL. Cardiopulmonary responses to continuous positive airway pressure in acute asthma. J Crit Care . 1993;8(2):87-92.

Ganesh A, Shenoy S, Doshi V, Rishi M, Molnar J. Use of noninvasive ventilation in adult patients with acute asthma exacerbation. Am J Ther. 2015;22(6):431-4.

Fernández MM, Villagrá A, Blanch L, Fernández R. Non-invasive mechanical ventilation in status asthmaticus. Intensive Care Med. 2001;27(3):486-92.

Murase K, Tomii K, Chin K, Tsuboi T, Sakurai A, Tachikawa R, et al. The use of non-invasive ventilation for life-threatening asthma attacks: Changes in the need for intubation. Respirology. 2010;15(4):714-20.

Stefan MS, Nathanson BH, Lagu T, Priya A, Pekow PS, Steingrub JS, et al. Outcomes of Noninvasive and Invasive Ventilation in Patients Hospitalized with Asthma Exacerbation. Ann Am Thorac Soc. 2016;13(7):1096-104.

Soroksky A, Stav D, Shpirer I. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest. 2003;123(4):1018-25.

Soma T, Hino M, Kida K, Kudoh S. A prospective and randomized study for improvement of acute asthma by non-invasive positive pressure ventilation (NPPV). Intern Med. 2008;47(6):493-501.

Gupta D, Nath A, Agarwal R, Behera D. A prospective randomized controlled trial on the efficacy of noninvasive ventilation in severe acute asthma. Respir Care. 2010;55(5):536-43.

Brandao DC, Lima VM, Filho VG, Silva TS, Campos TF, Dean E, et al. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma. J Asthma. 2009;46(4):356-61.

Baudin F, Buisson A, Vanel B, Massenavette B, Pouyau R, Javouhey E. Nasal high flow in management of children with status asthmaticus: a retrospective observational study. Ann Intensive Care. 2017;7(1):55.

Pilar J, Modesto IAV, Lopez-Fernandez YM, Lopez-Macias O, Garcia-Urabayen D, Amores-Hernandez I. High-flow nasal cannula therapy versus non-invasive ventilation in children with severe acute asthma exacerbation: An observational cohort study. Med Intensiva. 2017;41(7):418-24.

Pendergraft TB, Stanford RH, Beasley R, Stempel DA, Roberts C, McLaughlin T. Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations. Ann Allergy Asthma Immunol. 2004;93(1):29-35.

Quintard H, l'Her E, Pottecher J, Adnet F, Constantin JM, De Jong A, et al. Intubation and extubation of the ICU patient. Anaesth Crit Care Pain Med. 2017;36(5):327-41.

Marchello C, Dale AP, Thai TN, Han DS, Ebell MH. Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis. Ann Fam Med. 2016;14(6):552-66.

Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352(20):2082-90.

Gielen V, Johnston SL, Edwards MR. Azithromycin induces anti-viral responses in bronchial epithelial cells. Eur Respir J. 2010;36(3):646-54.

Kobayashi Y, Wada H, Rossios C, Takagi D, Higaki M, Mikura S, et al. A novel macrolide solithromycin exerts superior anti-inflammatory effect via NF-κB inhibition. J Pharmacol Exp Ther. 2013;345(1):76-84.

Johnston SL, Blasi F, Black PN, Martin RJ, Farrell DJ, Nieman RB. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med. 2006;354(15):1589-600.

Johnston SL, Szigeti M, Cross M, Brightling C, Chaudhuri R, Harrison T, et al. Azithromycin for Acute Exacerbations of Asthma : The AZALEA Randomized Clinical Trial. JAMA Intern Med. 2016;176(11):1630-7.

Graham VA, Milton AF, Knowles GK, Davies RJ. Routine antibiotics in hospital management of acute asthma. Lancet. 1982;1(8269):418-20.

Graham V, Lasserson T, Rowe BH. Antibiotics for acute asthma. Cochrane Database Syst Rev. 2001(3):Cd002741.

Cundiff KM, Gerard JM, Flood RG. Crit Care Interventions for Asthmatic Patients Admitted From the Emergency Department to the Pediatric Intensive Care Unit. Pediatr Emerg Care. 2018;34(6):385-9.

Maue DK, Krupp N, Rowan CM. Pediatric asthma severity score is associated with Crit Care interventions. World J Clin Pediatr. 2017;6(1):34-9.

Muntean IA, Leru PM, Pintea I, Bocsan IC, Dobrican CT, Deleanu D. A retrospective study regarding the influence of COVID-19 disease on asthma. BMC Pulm Med. 2023;23(1):22.

Fletcher M, van der Molen T, Lenney W, Boucot I, Aggarwal B, Pizzichini E. Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic. Adv Ther. 2022;39(4):1457-73.

Primary Care Respiratory Society UK. PCRS Pragmatic Guidance. Diagnosing and managing asthma attacks and people with COPD presenting in crisis during the UK COVID 19 epidemic. 2020. https://www.pcrs-uk.org/sites/pcrs-uk.org/files/resources/COVID19/PCRS-COVID-19-Pragmatic-Guidance-v4-07-May-2020.pdf. Accessed 2 July 2021

England N, Improvement N. Primary Care and Community Respiratory Resource pack for use during COVID-19. London: NHS. 2020.

Kew KM, Flemyng E, Quon BS, Leung C. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database of Syst Rev. 2022(9).

Green I, Merzon E, Vinker S, Golan-Cohen A, Magen E. COVID-19 Susceptibility in Bronchial Asthma. J Allergy Clin Immunol Pract. 2021;9(2):684-92.e1.

Chhiba KD, Patel GB, Vu THT, Chen MM, Guo A, Kudlaty E, et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol. 2020;146(2):307-14.e4.

Huang BZ, Chen Z, Sidell MA, Eckel SP, Martinez MP, Lurmann F, et al. Asthma Disease Status, COPD, and COVID-19 Severity in a Large Multiethnic Population. J Allergy Clin Immunol Pract. 2021;9(10):3621-8.e2.

Bloom CI, Drake TM, Docherty AB, Lipworth BJ, Johnston SL, Nguyen-Van-Tam JS, et al. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. Lancet Respir Med. 2021;9(7):699-711.

Calmes D, Graff S, Maes N, Frix AN, Thys M, Bonhomme O, et al. Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection. J Allergy Clin Immunol Pract. 2021;9(1):160-9.

O'Beirne SL, Salit J, Kaner RJ, Crystal RG, Strulovici-Barel Y. Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids. Respir Res. 2021;22(1):200.

Schultze A, Walker AJ, MacKenna B, Morton CE, Bhaskaran K, Brown JP, et al. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. The Lancet Respir Med. 2020;8(11):1106-20.

Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, et al. The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells. J Virol. 2020;95(1):e01648-20.

Klimek L, Akdis CA, Jutel M, Zuberbier T, Bousquet J. Inhaled corticosteroids in early COVID‐19—A tale of many facets. Allergy. 2021;76(11):3540-2.

Adir Y, Humbert M, Saliba W. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: nationwide real-world evidence. J Allergy Clin Immunol. 2021;148(2):361-7. e13.

Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430-6.

Kumar K, Hinks TS, Singanayagam A. Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used? Am J Physiol Lung Cell Mol Physiol. 2020;318(6):L1244-L7.

Choi YJ, Park J-Y, Lee HS, Suh J, Song JY, Byun MK, et al. Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur Respir J. 2021;57(3).

Vasanthakumar N. Beta‐adrenergic blockers as a potential treatment for COVID‐19 patients. BioEssays. 2020;42(11):2000094.

Rodrigo GJ, Castro-Rodriguez JA. Heliox-driven β2-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2014;112(1):29-34.

Bonds RS, Midoro-Horiuti T. Estrogen effects in allergy and asthma. Curr Opin Allergy Clin Immunol. 2013;13(1):92-9.

Camargo CA, Jr., Smithline HA, Malice MP, Green SA, Reiss TF. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med. 2003;167(4):528-33.

Watts K, Chavasse RJ. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children. Cochrane Database Syst Rev. 2012;2012(5):Cd006100.